Fennec Pharmaceuticals FENC
$ 5.94
1.71%
Quarterly report 2024-Q3
added 11-08-2024
Fennec Pharmaceuticals Balance Sheet 2011-2024 | FENC
Annual Balance Sheet Fennec Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
17.7 M | 1.12 M | - | -30.3 M | -13.6 M | -22.8 M | -28.3 M | -3.93 M | -942 K | -2.31 M | -1.66 M | -2.3 M | -5.3 M |
Long Term Debt |
30.9 M | 24.9 M | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
21 K | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
30.9 M | 24.9 M | 4.99 M | - | - | - | - | - | - | - | - | - | - |
Total Current Liabilities |
7.55 M | 4.61 M | 1.65 M | 2.35 M | 2.27 M | 1.64 M | 1.64 M | 402 K | 471 K | 1.76 M | 3.21 M | 7.32 M | 5.47 M |
Total Liabilities |
38.5 M | 29.5 M | 6.64 M | 2.35 M | 2.27 M | 1.64 M | 1.64 M | 402 K | 471 K | 1.76 M | 3.21 M | 7.32 M | 5.47 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-219 M | -203 M | -179 M | - | -144 M | -131 M | -121 M | -114 M | -112 M | -111 M | -109 M | -111 M | -105 M |
Total Assets |
26.9 M | 26.9 M | 22.4 M | 31.4 M | 14.1 M | 23 M | 28.4 M | 3.97 M | 1.02 M | 2.37 M | 1.75 M | 2.36 M | 5.35 M |
Cash and Cash Equivalents |
13.3 M | 23.8 M | 21.1 M | 30.3 M | 13.6 M | 22.8 M | 28.3 M | 3.93 M | 942 K | 2.31 M | 1.66 M | 2.3 M | 5.3 M |
Book Value |
-11.6 M | -2.57 M | 15.8 M | 29.1 M | 11.9 M | 21.3 M | 26.8 M | 3.57 M | 548 K | 613 K | -1.46 M | -4.96 M | -120 K |
Total Shareholders Equity |
-11.6 M | -2.57 M | 15.8 M | 29.1 M | 11.9 M | 21.3 M | 26.8 M | 3.57 M | 548 K | 613 K | -1.46 M | -4.96 M | -119 K |
All numbers in USD currency
Quarterly Balance Sheet Fennec Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
32.1 M | 31.8 M | 31.3 M | - | 25.6 M | 25.4 M | 25.1 M | - | 25 M | 4 M | 4.5 M | 5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
56.7 M | 56.8 M | 56.3 M | 30.9 M | 25.6 M | 25.4 M | 25.1 M | 24.9 M | 24.7 M | 3.99 M | 4.49 M | 4.99 M | 4.99 M | 4.99 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
64.1 M | 64.5 M | 66.2 M | 38.5 M | 29.6 M | 29.2 M | 29.2 M | 29.5 M | 27.6 M | 7.03 M | 6.62 M | 6.64 M | 7 M | 5.83 M | - | 2.35 M | 2.35 M | 2.35 M | - | 2.27 M | - | - | - | 1.64 M | 2.08 M | 847 K | 1.17 M | 1.64 M | 1.64 M | 1.64 M | 1.64 M | 402 K | 402 K | 402 K | 402 K | 471 K | 471 K | 471 K | 471 K | 1.76 M | 1.76 M | 1.76 M | 1.76 M | 3.21 M | 3.21 M | 3.21 M | 3.21 M | 7.32 M | 7.32 M | 7.32 M | 7.32 M | 5.47 M | 5.47 M | 5.47 M | 5.47 M |
Deferred Revenue |
248 K | 252 K | 252 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-218 M | -212 M | -206 M | -219 M | -217 M | -215 M | -209 M | -203 M | -196 M | -188 M | -183 M | -179 M | -175 M | -171 M | -167 M | -162 M | -162 M | -162 M | -148 M | -144 M | -144 M | -144 M | -144 M | -131 M | -131 M | -131 M | -131 M | -121 M | -121 M | -121 M | -121 M | -114 M | -114 M | -114 M | -114 M | -112 M | -112 M | -112 M | -112 M | -111 M | -111 M | -111 M | -111 M | -109 M | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
58.9 M | 63.2 M | 69.2 M | 26.9 M | 19 M | 19.4 M | 21.8 M | 26.9 M | 30.4 M | 15.6 M | 19.1 M | 22.4 M | 26 M | 28.1 M | 27.8 M | 31.4 M | 31.4 M | 31.4 M | 10.4 M | 14.1 M | 14.1 M | 14.1 M | 14.1 M | 23 M | 23 M | 23 M | 23 M | 28.4 M | 9.89 M | 28.4 M | 28.4 M | 3.97 M | 3.97 M | 3.97 M | 3.97 M | 1.02 M | 1.02 M | 1.02 M | 1.02 M | 2.37 M | 2.37 M | 2.37 M | 2.37 M | 1.75 M | 1.75 M | 1.75 M | 1.75 M | 2.36 M | 2.36 M | 2.36 M | 2.36 M | 5.35 M | 5.35 M | 5.35 M | 5.35 M |
Cash and Cash Equivalents |
40.3 M | 43.1 M | 51.2 M | 13.3 M | 12.4 M | 15 M | 18.4 M | 23.8 M | 29.8 M | 14.9 M | 18.3 M | 21.1 M | 24.3 M | 27.3 M | 26.8 M | 30.3 M | 30.3 M | 30.3 M | 9.9 M | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 22.8 M | 22.8 M | 22.8 M | 22.8 M | 28.3 M | 28.3 M | 28.3 M | 28.3 M | 3.93 M | 3.93 M | 3.93 M | 3.93 M | 942 K | 942 K | 942 K | 942 K | 2.31 M | 2.31 M | 2.31 M | 2.31 M | 1.66 M | 1.66 M | 1.66 M | 1.66 M | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 5.3 M | 5.3 M | 5.3 M | 5.3 M |
Book Value |
-5.17 M | -1.36 M | 3.01 M | -11.6 M | -10.5 M | -9.73 M | -7.34 M | -2.57 M | 2.8 M | 8.54 M | 12.5 M | 15.8 M | 19 M | 22.3 M | 27.8 M | 29.1 M | 29.1 M | 29.1 M | 10.4 M | 11.9 M | 14.1 M | 14.1 M | 14.1 M | 21.3 M | 20.9 M | 22.1 M | 21.8 M | 26.8 M | 8.24 M | 26.8 M | 26.8 M | 3.57 M | 3.57 M | 3.57 M | 3.57 M | 548 K | 548 K | 548 K | 548 K | 613 K | 613 K | 613 K | 613 K | -1.46 M | -1.46 M | -1.46 M | -1.46 M | -4.96 M | -4.96 M | -4.96 M | -4.96 M | -120 K | -120 K | -120 K | -120 K |
Total Shareholders Equity |
-5.17 M | -1.36 M | 3.01 M | -11.6 M | -10.5 M | -9.73 M | -7.34 M | -2.57 M | 2.8 M | 8.54 M | 12.5 M | 15.8 M | 19 M | 22.3 M | 24.9 M | 29.1 M | 29.1 M | 29.1 M | 8.46 M | 11.9 M | 11.9 M | 11.9 M | 11.9 M | 21.3 M | 21.3 M | 21.3 M | 21.3 M | 26.8 M | 26.8 M | 26.8 M | 26.8 M | 3.57 M | 3.57 M | 3.57 M | 3.57 M | 548 K | 548 K | 548 K | 548 K | 613 K | 613 K | 613 K | 613 K | -1.46 M | -1.46 M | -1.46 M | -1.46 M | -4.96 M | -4.96 M | -4.96 M | -4.96 M | -120 K | -120 K | -120 K | -120 K |
All numbers in USD currency